Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by DEYI, X.
Right arrow Articles by SHUQIU, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by DEYI, X.
Right arrow Articles by SHUQIU, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1981 Oxford University Press

research-article

The Inhibition and Protection of Cholinesterase by Physostigmine and Pyridostigmine Against Soman Poisoning in vivo

XIA DEYI, WANG LINXIU and PEI SHUQIU

Laboratory of Molecular Pharmacology, Institute of Basic Medical Sciences 11 Taiping Road, West Suburb, Beijing, The People's Republic of China

It has been shown that some reversible cholinesterase (ChE) inhibitors as physostigmine and pyridostigmine are prophylactically effective in organophosphate poisoning. The inhibition and protection of ChE against Soman poisoning with the above mentioned drugs was investigated in mice.

  1. Physostigmine and pyridostigmine significantly inhibited the ChE in whole blood in vivo and their inhibitory potencies with equitoxic doses were approximately equal (1/5 LD50 about 30%; 1/2 LD50 about 45% respectively). Physostigmine also significantly inhibited brain ChE and its potency was slightly weaker than that in blood; but pyridostigmine only slightly inhibited brain ChE (17%) with large dose (1/2 LD50). The extent of inhibition was in parallel with the dosage of the drugs used.
  2. Physostigmine had definite protection in the blood and brain ChE against Soman poisoning. The extent of protection was in parallel with the dosage used. The protection of blood ChE by pyridostigmine was weaker than that by physostigmine. There was no protection of brain ChE by pyridostigmine.
  3. The inhibitory potency of equitoxic doses of physostigmine and pyridostigmine in the ChE of diaphragm muscle was equal too (1/2 LD50 about 45%), and the protective effect of physostigmine was still greater than that of pyridostigmine in Soman poisoning.
  4. The time course of blood ChE inhibition by physostigmine in vivo was of short duration. While 30 minutes after administration of physostigmine, the ChE activity gradually recovered and it returned to normal level after 4 hours. The blood ChE inhibition by pyridostigmine reached a peak level after 2 hours, and the ChE activity slowly increased after 4 hours, but there was 30% of ChE activity still inhibited after 8 hours.
  5. Physostigmine and pyridostigmine, the reversible ChE inhibitors with carbamate structure, have definite ChE protection against Soman poisoning. The prophylactic efficacy was obviously correlated with their ChE protective potency. Evaluating physostigmine and pyridostigmine based on their efficacy, toxicity, adverse effects, duration, availability and stability, we recommend that pyridostigmine is the drug of choice in the prophylaxis against nerve gas poisoning.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.